BRIEF published on 09/08/2025 at 22:05, 9 months 13 days ago Abivax Reports First Half 2025 Financial Performance Financial Results Research And Development Convertible Notes Public Offering Cash Reserves
PRESS RELEASE published on 09/08/2025 at 22:00, 9 months 13 days ago Abivax présente ses résultats financiers du premier semestre 2025 Abivax présente ses résultats financiers du premier semestre 2025, avec une perte nette de 100,8 millions d'euros. Principalement axée sur le développement de thérapies pour les maladies inflammatoires Résultats Financiers Abivax Perte Nette Thérapies Premier Semestre 2025
PRESS RELEASE published on 09/08/2025 at 22:00, 9 months 13 days ago Abivax Presents First Half 2025 Financial Results Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF published on 09/02/2025 at 11:00, 9 months 20 days ago JP Morgan Chase & Co. Crosses Threshold at ABIVAX Voting Rights Capital Abivax Threshold Crossing JP Morgan
BRIEF published on 09/02/2025 at 11:00, 9 months 20 days ago Franchissement de seuil par J.P. Morgan Chase & Co. chez ABIVAX Capital Droits De Vote Franchissement De Seuil Abivax J.P. Morgan
PRESS RELEASE published on 09/02/2025 at 10:55, 9 months 20 days ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de la société ABIVAX par la société J.P. Morgan Chase & Co. indirectement, le 28 août 2025 Déclaration Franchissement De Seuil Abivax 5% J.P. Morgan Chase
BRIEF published on 08/13/2025 at 18:05, 10 months 8 days ago ABIVAX: Update on capital and voting rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 10 months 8 days ago ABIVAX : Mise à jour sur le capital et les droits de vote Euronext Paris Droits De Vote Capital Social AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 10 months 8 days ago ABIVAX: Données sur les actions et droits de vote au 31 juillet 2025 Euronext Paris Droits De Vote Biotechnologie Actions Réglementation AMF
BRIEF published on 08/13/2025 at 18:05, 10 months 8 days ago ABIVAX: Share and voting rights data as of July 31, 2025 Euronext Paris Voting Rights Biotechnology Actions AMF Regulations
Published on 06/22/2026 at 15:58, 1 hour 58 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 2 hours 26 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 2 hours 56 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 3 hours 55 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 3 hours 56 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 17:35, 21 minutes ago Heidrick & Struggles Strengthens Board with Appointment of AI and Talent Leaders Aseem Datar and Leanne Wood
Published on 06/22/2026 at 16:21, 1 hour 34 minutes ago Fuller, Smith & Turner PLC: Share Buyback Programme
Published on 06/22/2026 at 16:05, 1 hour 51 minutes ago ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 2 hours 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 17:45, 11 minutes ago Déclaration des transactions sur actions propres réalisées du 15/06/2026 au 21/06/2026
